Mylan NV (NASDAQ:MYL)

43.03
Delayed Data
As of Aug 26
 +0.18 / +0.42%
Today’s Change
37.59
Today|||52-Week Range
55.51
-20.42%
Year-to-Date

Today’s Trading

Previous close42.85
Today’s open43.11
Day’s range42.63 - 43.98
Volume8,349,591
Average volume (3 months)5,300,720
Market cap$22.9B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-27.35%
Earnings growth (this year)+15.81%
Earnings growth (next 5 years)+10.54%
Revenue growth (last year)+21.91%
P/E ratio18.5
Price/Sales2.84
Price/Book2.15

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+0.71+0.74%
ZTSZoetis Inc+0.29+0.57%
ALXNAlexion Pharmaceutic...+0.46+0.36%
BMRNBiomarin Pharmaceuti...+1.25+1.32%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$1.58
Annual revenue (last year)$9.5B
Annual profit (last year)$847.6M
Net profit margin8.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts

Partner Offers

NextAdvisor